Search filters

List of works by Antonina Azzolina

Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism

scientific article

Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells

scientific article

Biocompatible Lipid Nanoparticles as Carriers To Improve Curcumin Efficacy in Ovarian Cancer Treatment.

scientific article published on 23 January 2017

COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells.

scientific article published on 16 March 2011

Cationic Solid Lipid Nanoparticles as Non Viral Vectors for the Inhibition of Hepatocellular Carcinoma Growth by RNA Interference

scientific article published on 01 May 2018

Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells

scientific article

Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells

scientific article

Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells.

scientific article

GSK-3 in liver diseases: Friend or foe?

scientific article published on 14 May 2020

Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells

scientific article

Identification of an LPS-Induced Chemo-Attractive Peptide from Ciona robusta

scientific article published on 12 April 2020

Involvement of p38 and JNK MAPKs pathways in Substance P-induced production of TNF-alpha by peritoneal mast cells

scientific article published in April 2002

Molecular mechanisms of sorafenib action in liver cancer cells.

scientific article

Nanoassemblies Based on Supramolecular Complexes of Nonionic Amphiphilic Cyclodextrin and Sorafenib as Effective Weapons to Kill Human HCC Cells

scientific article

Nanoparticles of a polyaspartamide-based brush copolymer for modified release of sorafenib: In vitro and in vivo evaluation

scientific article published on 13 September 2017

Nanostructured lipid carriers-containing anticancer compounds: preparation, characterization, and cytotoxicity studies

scientific article published on February 2007

Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery

scientific article published on May 2007

Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells

scientific article published in April 2010

Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells.

scientific article

Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation

scientific article published on 21 June 2017

Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma

scientific article

Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.

scientific article published on 26 June 2007

Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells

scientific article

Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth.

scientific article

RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma

scientific article published on 04 November 2019

Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells

scientific article

Synthesis and characterization of polyaminoacidic polycations for gene delivery

scientific article published on 19 October 2005

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

scientific article

Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma

scientific article published on 24 December 2018

The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment

scientific article published on 09 June 2020

The novel NF-κB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism.

scientific article

The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells

scientific article published on February 2006